Manipal Hospitals Eastern India Private Limited, a subsidiary of Manipal Health Enterprises, has received two orders from GST authorities. These orders confirm a demand of approximately ₹3.77 crore concerning issues related to input tax credit, and another of ₹4.22 crore for the supply of drugs and consumables, along with penalties. The company is currently reviewing these orders and plans to exercise its right to appeal.
GST Orders Issued to Manipal Hospitals Subsidiary
Manipal Hospitals Eastern India Private Limited, formerly known as Medica Hospitals Private Limited, a subsidiary of Manipal Health Enterprises Limited, has been issued significant orders by the GST authorities. These orders stem from investigations into the company’s tax filings and operations.
Order Details and Financial Impact
The first order, received on August 14, 2026, from the Additional Commissioner of Revenue (Appeal), Large Taxpayers Unit, Kolkata, confirmed a demand of ₹3,77,52,668. This amount is related to issues primarily concerning input tax credit and outward supplies for the financial year 2019-20. The second order, dated September 11, 2026, from the Joint Commissioner, Large Taxpayers Unit, Kolkata, confirms a demand of ₹4,22,95,004 for the financial year 2021-22. This demand is attributed to the supply of drugs and consumables to inpatients.
Penalties and Next Steps
The order for FY 2021-22 also includes a penalty of ₹4,22,95,004 under Section 76(2) of the CGST Act, 2017. While these orders represent a substantial financial imposition, the company has stated that there is no material impact on its overall financial operations or other activities, as the orders are currently appealable. Manipal Health Enterprises Limited indicated that they will exercise their right to appeal these decisions.
The delay in intimation regarding these orders was attributed to the time taken to receive the relevant official documents from the authorities.
Source: BSE
